Patents by Inventor Andres J. Acosta

Andres J. Acosta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND MATERIALS FOR ASSESSING AND TREATING OBESITY
    Publication number: 20230358765
    Abstract: This document relates to methods and materials for assessing and/or treating obese mammals (e.g., obese humans). For example, methods and materials for using one or more interventions (e.g., one or more pharmacological interventions) to treat obesity and/or obesity-related comorbidities in a mammal (e.g., a human) identified as being likely to respond to a particular intervention (e.g., a pharmacological intervention) are provided.
    Type: Application
    Filed: July 12, 2023
    Publication date: November 9, 2023
    Inventors: Andres J. Acosta, Michael L. Camilleri
  • Methods and materials for assessing and treating obesity
    Patent number: 11740247
    Abstract: This document relates to methods and materials for assessing and/or treating obese mammals (e.g., obese humans). For example, methods and materials for using one or more interventions (e.g., one or more pharmacological interventions) to treat obesity and/or obesity-related comorbidities in a mammal (e.g., a human) identified as being likely to respond to a particular intervention (e.g., a pharmacological intervention) are provided.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: August 29, 2023
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Andres J. Acosta, Michael L. Camilleri
  • METHODS AND MATERIALS FOR ASSESSING AND TREATING OBESITY
    Publication number: 20210072259
    Abstract: This document relates to methods and materials for assessing and/or treating obese mammals (e.g., obese humans). For example, methods and materials for using one or more interventions (e.g., one or more pharmacological interventions) to treat obesity and/or obesity-related comorbidities in a mammal (e.g., a human) identified as being likely to respond to a particular intervention (e.g., a pharmacological intervention) are provided.
    Type: Application
    Filed: November 21, 2018
    Publication date: March 11, 2021
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Andres J. Acosta, Michael L. Camilleri